Oncology Ventures Fund I-A LP — Form D
Oncology Ventures Fund I-A LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2024-05-14. $5.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-05-14
- Form: D
- Accession: 0002022892-24-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $5.0M
- Minimum investment: $10K
- Investors: 37
- Date of first sale: 2024-04-30
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-513253
Issuer
- Name: Oncology Ventures Fund I-A LP
- CIK: 0002022892
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 160 EAST 38TH STREET, NEW YORK, NY, 10002
- Phone: 5168512311
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Ben Freeberg | Executive Officer | Boca Raton, FL |
| N/A Oncology Ventures GP I LLC | Executive Officer | New York, NY |
| N/A Oncology Ventures LLC | Executive Officer | New York, NY |
More